Abstract
STAT1 gain-of-function (GOF) is a primary immunodeficiency typically characterized by chronic mucocutaneous candidiasis (CMC), recurrent respiratory infections, and autoimmunity. Less commonly, also immunodysregulation polyendocrinopathy enteropathy X-linked (IPEX)-like syndromes with CMC, and combined immunodeficiency without CMC have been described. Recently, our group and others have shown that different mutation-specific mechanisms underlie STAT1 GOF in vitro, including faster nuclear accumulation (R274W), and reduced mobility (R321, N574I) to near immobility in the nucleus (T419R) upon IFNγ stimulation. In this work, we evaluated the transcriptomic fingerprint of the aforementioned STAT1 GOF mutants (R274W, R321S, T419R, and N574I) relative to STAT1 wild-type upon IFNγ stimulation in an otherwise isogenic cell model. The majority of genes up-regulated in wild-type STAT1 cells were significantly more up-regulated in cells expressing GOF mutants, except for T419R. In addition to the common interferon regulated genes (IRG), STAT1 GOF mutants up-regulated an additional set of genes, that were in part shared with other GOF mutants or mutation-specific. Overall, R274W and R321S transcriptomes clustered with STAT1 WT, while T419R and N574I had a more distinct fingerprint. We observed reduced frequency of canonical IFNγ activation site (GAS) sequences in promoters of genes up-regulated by all the STAT1 GOF mutants, suggesting loss of DNA binding specificity for the canonical GAS consensus. Interestingly, the T419R mutation, expected to directly increase the affinity for DNA, showed the most pronounced effects on the transcriptome. T419R STAT1 dysregulated more non-IRG than the other GOF mutants and fewer GAS or degenerate GAS promotor sequences could be found in the promoter regions of these genes. In conclusion, our work confirms hyperactivation of common sets of IFNγ-induced genes in STAT1 GOF with additional dysregulation of mutation-specific genes, in line with the earlier observed mutation-specific mechanisms. Binding to more degenerate GAS sequences is proposed as a mechanism toward transcriptional dysregulation in R274W, R321S, and N574I. For T419R, an increased interaction with the DNA is suggested to result in a broader and less GAS-specific response. Our work indicates that multiple routes leading to STAT1 GOF are associated with common and private transcriptomic fingerprints, which may contribute to the phenotypic variation observed in vivo.
Highlights
Signal Transducer and Activator of Transcription 1 (STAT1) gain-of-function (GOF) is a monogenic autosomal dominant (AD) disorder first described in 2011 [1, 2]
While the common phenotypic denominator is chronic mucocutaneous candidiasis [CMC— in 98% of the patients [4]], less frequent phenotypes were associated with STAT1 GOF, like John Cunningham (JC)-virus induced progressive multifocal leukoencephalopathy [5], immunodysregulation polyendocrinopathy enteropathy Xlinked (IPEX)-like syndromes with CMC [6, 7], Orf infection [8], and combined immunodeficiency (CID) without CMC [9]
We studied a subset of STAT1 GOF mutants (R274W, R321S, T419R, and N574I) that reside in different domains and at different interfaces of the STAT1 protein [24]
Summary
Signal Transducer and Activator of Transcription 1 (STAT1) gain-of-function (GOF) is a monogenic autosomal dominant (AD) disorder first described in 2011 [1, 2]. To date 105 different mutations in at least 400 patients [3] have been reported, all presenting with increased STAT1-dependent cellular responses and high levels of tyrosine phosphorylated STAT1 (pSTAT1) in different immune cells. STAT1 is a transcription factor of the STAT family, that plays a key role in the immune response and the Interferon (IFN) signaling pathway, modulating diverse cellular processes including proliferation, cell death and cell differentiation [11,12,13]. Following IFNγ stimulation, STAT1 is phosphorylated at Y701 [11] and the antiparallel homodimers change their conformation to parallel homodimers [16, 17], that in turn are imported into the nucleus to bind gamma interferon (IFNγ) activation site (GAS) sequences in promoter regions and, up- or down-regulate the transcription of interferon regulated genes (IRGs) [18,19,20]
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.